SLRX vs TECH
Salarius Pharmaceuticals Inc (SLRX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
SLRX currently screens at market cap $4.9M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the SLRX and TECH stock pages for the full models.
Not investment advice.